Sensitive Infrared Detection for In Vivo Imaging
BrightSite™ targeting agent solutions let you start work immediately using native cells and cell lines for which targeting agents have been developed. Costly and laborious evaluation of cell transfection reagents and optimization for a given cell system are eliminated. Results using native cells may also be more conducive to translational research.
LI-COR’s systematic development and optimization of targeting agents has provided the following ready-to-use solutions.
BrightSite™ Targeting Receptors
RGD - IRDye 800CW RGD Optical Probe & IRDye 680RD RGD Optical Probe
EGF - IRDye 800CW EGF Optical Probe & IRDye 680RD EGF Optical Probe
HA - IRDye 800CW HA Optical Probe & IRDye 680RD HA Optical Probe
Metabolism
2-DG - IRDye 800CW 2-DG Optical Probe
[Left] IRDye 800CW 2-DG Optical Probe (10 nmol) was used to detect subcutaneous A431 tumors. Probe signal is displayed in pseudo color and is merged with a grey scale white light image of the mouse.
Lymphatics
HA - IRDye 800CW HA Optical Probe & IRDye 680RD HA Optical Probe
Vasculature and Contrast
PEG - IRDye 800CW PEG Contrast Agent
Cell Trafficking and Biodistribution
CellVue® Cell Stains
IRDye Labeling Kits for Agent Development
IRDye Protein Labeling Kits
IRDye 800CW Streptavidin
IRDye Maleimides
IRDye NHS Esters
IRDye Carboxlylates
Additional IRDye Reagents
Download a copy of our Application Guide or contact us for further information.